SCHEMBL4355063

SCHEMBL4355063

Nc1nc(Cl)ncc1C(=O)c1cc(F)cc2ccoc12

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
XPO1 O14980 3/20 0.36
CYP3A4 P08684 1/20 0.33
CDK1 P06493 2/20 0.32
CDK4 P11802 2/20 0.32
CCND1 P24385 2/20 0.32
CDK2 P24941 2/20 0.32
NFKB1 P19838 5/20 0.32
ATF1 P18846 3/20 0.32
MAP4K4 O95819 2/20 0.32
CHRM5 P08912 1/20 0.32
JUN P05412 2/20 0.31
NFKB2 Q00653 2/20 0.31
RELA Q04206 2/20 0.31
CSNK1A1 P48729 1/20 0.30
CLK4 Q9HAZ1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4348794 0.88 NFKB1 (0.38) XPO1CYP3A4NFKB1ATF1JUN
SCHEMBL30367823 0.71 PARP1 (0.43)
Hydrochloric Acid SCHEMBL28438885 0.70 PARP1 (0.44)
SCHEMBL4823128 0.69 SLC22A12 (0.46) NFKB1
SCHEMBL16844542 0.68 MAPT (0.40) CYP3A4
SCHEMBL13538202 0.67 CSNK1A1 (0.43) XPO1NFKB1ATF1CHRM5JUN
SCHEMBL3833955 0.67 SLC22A12 (0.38)
SCHEMBL4356261 0.66 P4HB (0.31)
SCHEMBL13517566 0.66 CSNK1A1 (0.44) XPO1CYP3A4NFKB1JUNNFKB2
SCHEMBL16120968 0.66 CSNK1A1 (0.44) NFKB1ATF1JUNNFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7615634-B2 4-aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2009-11-10 US disclosed
US-7157455-B2 4-Aminopyrimidine-5-one derivatives HOFFMANN-LA ROCHE INC. (US) 2007-01-02 US disclosed
US-20060229330-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID J 2006-10-12 US disclosed
EP-1628619-A2 4-AMINOPYRIMIDINE-5-ONE F.HOFFMANN-LA ROCHE AG (CH) 2006-03-01 EP disclosed
US-20040162303-A1 4-aminopyrimidine-5-one derivatives BARTKOVITZ DAVID JOSEPH (US) 2004-08-19 US disclosed
WO-2004069139-A2 4-AMINOPYRIMIDIN-5-YL-METHANONE DERIVATIVES FOR INHIBITION OF CDK4 ACTIVITY F.HOFFMANN-LA ROCHE AG (CH) 2004-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162303-A1 4-aminopyrimidine-5-one derivatives CDK4, CDKL4, CDK6 XPO1 3699/4885CYP3A4 548/4885CDK1 6/4885
US-20060229330-A1 4-aminopyrimidine-5-one derivatives CDK4, CDKL4, CDK2 XPO1 2421/4885CYP3A4 1107/4885CDK1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.